Chordoma Study Led by Prof. Dr. Ömer Bayrak Receives TÜBİTAK Funding

The project titled “Investigation of the Therapeutic Effect of Brusatol and Oxaliplatin in Chordoma,” led by Prof. Dr. Ömer Bayrak of the Department of Medical Genetics, Faculty of Medicine, has been granted support under the TÜBİTAK 1002-A Short-Term Support Module.

We congratulate the project team and wish them a successful project management process.